Due to California’s penchant for legislating at the ballot box, the state has reigned as the top destination for industry campaign spending since even before the Supreme Court widened the door to corporate political donations with its 2010 Citizens United decision.
Europe already has many of the ingredients for successful biotech and pharma activity—top-tier academic research, a commitment to public research funding, a heritage of pharmaceutical giants stretching back to 1668 (when Merck was founded in Darmstadt, Germany), and a growing number of biotechs nurtured by regional biotech clusters (especially in Germany and France).
This week at Health Datapalooza, a group of medtech and pharma companies traded insights on the strategic partnerships they built with technology companies and what they learned in the process. But they also touched on how they collaborate with startups.
Johns Hopkins University took over the No. 1 spot on this week’s List of patents in Maryland. The private research institution obtained 133 patents in 2015, achieving a total of 454 patents in the last five years.
It would be easy to mistake the Universities at Shady Grove as a flagship public school, with its red-brick buildings and its state-of-the-art labs, library and fitness center.
Stafford County leaders voted to infuse $500,000 into the county’s Tech and Research Park.
The money from the county’s Economic Opportunity Fund will be used to launch a co-working space and business incubator at the Quantico Corporate Center site in North Stafford. Incubators attract start-up companies and entrepreneurs looking for temporary office and meeting space to grow their firms.
Not only have several of the top bioscience companies in our region grown in the past year, but we can already predict some of the biggest growth spurts we’ll see next.
Healthcare Interactive tacked on a few extra million dollars to its latest funding round.
The Glenwood-based company announced $3.4 million in additional funding. It’s a tack-on to the health planning company’s $8 million Series A announced in 2014.
Epigenomics AG, a German-American cancer molecular diagnostics company, with its U.S. headquaters in Germantown, MD, announced that LabCorp® to offer Epi proColon®, a blood-based test for colorectal cancer screening, in the U.S.
With its U.S. headquarters located within the Germantown Innovation Center, Epigenomics recently announced that its blood-based test for colorectal cancer screening, Epi proColon®, will be available in the U.S. This deal is yet another example of the success of a company in Montgomery County’s Business Innovation Network, specifically in the life sciences incubator, earning significant revenue from the marketplace. “It’s truly hard to express how proud we are when an incubator company makes it through FDA approvals and gets their product to market,” said Sally Sternbach, Acting Director of Montgomery County Department of Economic Development.
Redonda Miller, senior vice president of medical affairs for the Johns Hopkins Health System and vice president of medical affairs for The Johns Hopkins Hospital, will assume the role of president of the Johns Hopkins Hospital on July 1.
She will succeed current president Ronald R. Peterson, becoming the hospital’s 11th president and the first woman to hold the post since the hospital was founded in 1889.
